proliferative diabetic retinopathy or severe non-proliferative diabetic retinopathy.
Conditions
Interventions
Intervention 1: Intervention group: Twenty patients with proliferative diabetic retinopathy or severe non-proliferative diabetic retinopathy or one eye with proliferative diabetic retinopathy and the
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Proliferative diabetic retinopathy or severe non- proliferative diabetic retinopathy patients Patients with informed consent Patients with proper collaboration to perform a primetry
Exclusion criteria
Exclusion criteria: Patients with ocular infections Glaucoma or uveitis patients Patients with degenerative or inherited retinal disease which leads to visual field damage Any ocular disease that impairs the performance of primetry Lack of proper access to patient to follow up Diabetic maculopathy History of previous laser retinal treatment turbid media
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Conventional Pan retinal Photocoagulation Effects on Diabetic Patients visual field. Timepoint: One day prior to the PRP and one month after the initial PRP. Method of measurement: Humphrey 30-II SITA Standard perimetry.;Pattern Scanning Pan retinal Photocoagulation Effects on Diabetic Patients visual field. Timepoint: One day prior to the PRP and one month after the initial PRP. Method of measurement: Humphrey 30-II SITA Standard perimetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity. Timepoint: One day prior to the PRP and one month after the initial PRP. Method of measurement: Snellen chart. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactatena latifi
Tabriz University of Medical Sciences
Outcome results
None listed